Amedisys Shares Are Too Pricey For A Declining Business: Looking for Single Digits

Amedisys, Inc. (AMED) reported 4Q and year-end earnings Tuesday, March 12, and the key highlight was the company’s 2013 EPS guidance range of $0.60-$0.70, substantially below the Street’s $0.77 estimate. Analysts EPS estimates were lowered when the company reported its third quarter 2012 earnings miss (2013 EPS forecasts back then called for $0.93 a share), hence, the business continues to deteriorate and the earnings trough has not yet been reached.

Read more »

Medical Cost Estimators Help Consumers Shop Around

Often, consumers have no idea how much a given medical procedure costs until they’re hit with the bill.

Read more »